-
SkIN Canada NewsSkIN Canada News
-
-
-
-
-
Featured profiles
-
-
-
From the SkIN Canada Training Committee Hub
-
-
-
From the SkIN Canada Patient Engagement hub
-
-
News from Other Organizations
-
-
-
-
-
Recent Publications by SkIN Canada Members
-
-
-
-
Early-Career Investigator

Dr. Mélanie Laurin is a regular researcher in the Oncology axis of the CHU of Quebec – Laval University Research Center. She is also an associate professor in the Department of Molecular Biology, Medical Biochemistry and Pathology at Laval University. Her research activities focus on understanding the molecular mechanisms that orchestrate skin embryonic development and how these can contribute when deregulated to skin cancer progression. Throughout her career, Dr. Laurin’s work has been published in prestigious journals. Notably, one of her breakthroughs received a best publication award from the CIHR Institute of Cancer Research and was identified as a Top 10 discoveries funded by the Canadian Cancer Society in 2013. She is currently a Co-chair for the Skin Cancer Working Group of SkIN Canada and an active member of the Training Committee for SkIN Canada.
Summer 2023
Featured profile: Patient Research Partner – Natalie Kermany

Natalie Kermany is a Policy & Planning Analyst at the Natural Sciences and Engineering Research Council of Canada (NSERC) and is passionate about advocating for patients living with skin conditions. She is currently the Patient Research Partner (PRP) for the Training Committee of SkIN Canada, and has also served as a Grant Reviewer for the Canadian Skin Patient Alliance (CSPA). Natalie has a Master of Science Degree focused in Animal Behaviour from the University of Ottawa, and her interests include dermatology, intersectional environmentalism, equitable healthcare, and anti-racism work.
1. What inspired you to become an advocate for patients with skin conditions? As a child, I was diagnosed with vitiligo – a skin condition that causes a loss of pigment in an individual’s skin, and appears as light patches that vary greatly in size and number. Through growing up with vitiligo, I learned first-hand about the stigma associated with skin conditions, and the lack of awareness surrounding them. Though I am grateful that my diagnosis did not affect my physical health, it had a large impact on my mental health. It was my personal experience living with this skin condition which inspired me to become an advocate for other patients, as I knew that I wanted to bring awareness to the mental health impacts that skin conditions can cause, and help improve other patients’ quality of life.
2. What are some of the challenges you had to face while trying to accomplish your goals? One of the main challenges that I have experienced is learning to be confident in my own skin (literally and figuratively). As a young woman, I often struggled with personal doubt and imposter syndrome. Over time, I have learned that everyone has their own unique experience that they bring to the table, and that each person can contribute a valuable perspective to a discussion. As a patient research partner, I try to remind myself of this while I interact with other members on the Training Committee, and am grateful for the chance to share my perspective with such a talented group.
3. What are your hopes for the future of skin research to include patients and patient research representatives on research teams? I feel optimistic about the future of research teams in terms of including patients and patient research partners in their research process. I continue to see more collaborative opportunities for patients to get involved, and I think that interdisciplinary research teams which consider patient perspectives are becoming more common. I think that the next crucial step is not only for patients to be involved, but for the patient partners to include people of colour who continue to be underrepresented in skin research.
4. What are the roles and contributions of Patient Research Partners (PRPs) to SkIN Canada and skin research? As a patient research partner at SkIN Canada, you help to provide your own perspective, as well as the perspective of other skin patients, on the different SkIN Canada research activities. For myself, this looks like providing feedback at Training Committee meetings, where we develop leadership and training opportunities for research trainees. Overall, PRP’s ensure that patient perspectives are taken into account at each step of the research process, which ensures that the research continues to benefit patients at the end of the day.
5. In your view, what are some of the obstacles that may dissuade patients from participating as PRPs? I think that the first obstacle for patients is knowing about these opportunities in the first place. Often times, opportunities to get involved are not advertised widely outside of academic or research spaces, so it can be difficult for everyday patients to find out about them even if they would be interested in joining. The second large obstacle is the time commitment – many patients work full time or more and cannot dedicate time within the work week to participate in a research team on a volunteer basis. It is often those who come from a more privileged background who can afford to take time off to participate, or who have the resources to do so. Lastly, I think it can be intimidating for patients to get involved in an academic research team. Patients may lack trust in the research enterprise for several reasons, or may feel that they will not be able to contribute in an academic setting.
6. How does your participation in SkIN Canada’s Training Committee help advance your work as a skin patient advocate? This role helps me to advance my work as a skin patient advocate, as I am able to contribute to an organization that produces patient-relevant research that improves the skin health of Canadians. Being involved as a patient research partner not only allows me to provide advice on planning, implementing, and evaluating the Network activities, but also be part of a greater interdisciplinary community of skin research leaders. Ultimately, being able to have my voice heard as a skin patient with lived experience allows me to advocate on behalf of the skin patient community effectively, and gives me the necessary platform to give back to my community.
Recap of SkIN Canada Workshops at 10th Annual Skin Research Group of Canada (SRGC) MeetingÂ
Workshop 1 (November 9)
Topic:Â Patient Research Engagement (Rare Skin Conditions/Skin of Color)

Moderator: Rachael Manion. Topic: Patient Research Engagement – Rare Skin Conditions/Skin of Color.
Workshop 2 (November 10)
Topic: Equity, Diversity and Inclusion (EDI)Â

Speaker 1: Dr. Diego Herrero Title: Equity, Diversity and Inclusion. Approaches to Enhance Innovation and Social Relevance of Research Projects.

Speaker 2: Dr. Nitika Pai. Title: Oh Melanin- did you just skin me? Colorism and its impact on EDI in the workplace.
Dr. Nitika Pai, a professor at McGill University and scientist at the RI-MUHC, gave her perspective on the impact of colorism on EDI in the workplace (PDF of presentation to be added to SkIN Canada website).
Skin Canada Travel and Mobility Awards – Next Application Deadline is May 15, 2024
1. The deadline for the next SkIN Canada Trainee Travel Award is Wednesday May 15 (2024) before 11:59 PM ET. SkIN Canada provides partial funding for trainees to attend conferences as part of their training experience. A limited number of awards are available each year on a competitive basis. Applicants who have previously received funding through this program in the fiscal year are not eligible to receive funding until the following fiscal year. The value of the SkIN Canada Travel Award is a maximum of $1,000 CAD.Â
Â
2. The deadline for the next SkIN Canada Trainee Mobility Award is Wednesday May 15 (2024) before 11:59 PM ET. The SkIN Canada Trainee Mobility Award provides funding for trainees in the field of skin research to study and conduct research for a brief period in a laboratory other than their own within Canada or abroad as part of their training experience. A limited number of awards are available each year on a competitive basis.  There will be two competition periods per year, one in May and one in October. Applicants are eligible for the award only once during a particular training period or level of study (e.g. MSc, Ph.D., Clinical residency, or Postdoctoral training).
    The value of the Skin Canada Trainee Mobility Award is up to $4,000 which can be used for the trainee’s research in a host laboratory within Canada or abroad for a period ranging from 2 weeks to 6 months.Â
GRIPP (Guidance for Reporting Involvement of Patients and the Public)
Although there has been more research on how to involve patients and the public in research, how patients and the public are involved and how that’s measured and evaluated is still inconsistent. This prompted a study to develop an international consensus on the key items to report to enhance the quality, transparency, and consistency of the Patient and Public Involvement (PPI) evidence base and to collaboratively involve patients as research partners at all stages in the development of GRIPP (Guidance for Reporting Involvement of Patients and the Public).
This guideline was published simultaneously in 2 journals. You can read the guideline in either of these journals using the links below.
BMJ. 2017;358:j3453. PMID: 28768629
Res Involv Engagem. 2017;3:13. PMID: 29062538
Â
CIHR-IMHA Inclusive Research Excellence Prizes Funding Opportunity


NCOHRÂ Call for Abstracts

The Association of Canadian Faculties of Dentistry (ACFD) / Canadian Association for Dental Research (CADR) and the Network for Canadian Oral Health Research (NCOHR) invites submission of research abstracts from students and junior faculty members (no more than 10 years beyond the receipt of the PhD or other equivalent degrees) at Canadian Universities for topics related to oral health. Submissions will be peer-reviewed by a conference committee panel, and selected authors will be invited to present a poster at the Canadian Oral Health Summit (COHS) held at Dalhousie University in Halifax, Nova Scotia on June 20th to 22nd, 2024.

More than Skin Deep: Mental Health Grant
Genodermatoses Network Meeting

- Croitoru DO, Brooks SG, Nathanielsz N, et al. Predictors of severity in paradoxical psoriasis from biologic therapies: A systematic review. J Am Acad Dermatol. Feb 2023;88(2):471-473.https://www.ncbi.nlm.nih.gov/pubmed/35718193
- O’Toole A, Gooderham M. Topical Roflumilast for Plaque Psoriasis. Skin Therapy Lett. Sep 2023;28(5):1-4.https://www.ncbi.nlm.nih.gov/pubmed/37734074
- Joly-Chevrier M, Gelinas A, Ghazal S, et al. Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review. Cancers. Sep 7 2023;15(18).https://www.ncbi.nlm.nih.gov/pubmed/37760419
- Osman M, Martins KJB, Wong KO, et al. Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study. Scientific reports. Sep 30 2023;13(1):16444.https://www.ncbi.nlm.nih.gov/pubmed/37777591
- Graff P, Woerz D, Wilzopolski J, et al. Extracellular Matrix Remodeling in Atopic Dermatitis Harnesses the Onset of an Asthmatic Phenotype and Is a Potential Contributor to the Atopic March. The Journal of investigative dermatology. Oct 12 2023.https://www.ncbi.nlm.nih.gov/pubmed/37838332
Â
Â
Wound Healing, Fibrosis and Regeneration
- Attiogbe E, Larochelle S, Chaib Y, et al. An in vitro autologous, vascularized, and immunocompetent Tissue Engineered Skin model obtained by the self-assembled approach. Acta biomaterialia. Sep 15 2023;168:361-371.https://www.ncbi.nlm.nih.gov/pubmed/37419164
- Khalaf F, Hutter MF, Jeschke MG. Traversing the blaze: Uncovering the challenges in burn care for older adults. Surgery. Oct 11 2023.https://www.ncbi.nlm.nih.gov/pubmed/37833154
- Sanchez-Espino LF, Sibbald C, Stimec J, Laxer RM, Pope E. Characteristics and onset of presentation of pediatric stiff skin syndrome: A retrospective cohort study of 11 patients in a tertiary care center. Pediatr Dermatol. Oct 20 2023.https://www.ncbi.nlm.nih.gov/pubmed/37864376
- Magne B, Demers A, Savard E, et al. Speeding up the production of clinical-grade skin substitutes using off-the-shelf decellularized self-assembled dermal matrices. Acta biomaterialia. Sep 1 2023;167:249-259.https://www.ncbi.nlm.nih.gov/pubmed/37285897
- Yang Y, Gomez N, Infarinato N, et al. The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates. Nature cell biology. Jul 24 2023.https://www.ncbi.nlm.nih.gov/pubmed/37488435
Â
Skin and Other Cancers
- Bergeron A, Nessim C, Kleiner O, et al. SkIN Canada Priority Setting Initiative ranks the Top Ten evidence uncertainties for Merkel cell carcinoma. The British journal of dermatology. Oct 21 2023.https://www.ncbi.nlm.nih.gov/pubmed/37864824
- Mohsen ST, Price EL, Chan AW, et al. Incidence, Mortality, and Survival of Merkel Cell Carcinoma: A Systematic Review of Population Based-Studies. The British journal of dermatology. Oct 24 2023.https://www.ncbi.nlm.nih.gov/pubmed/37874770
- Venables ZC, Levell NJ. Caution required in interpreting primary care vitiligo skin cancer data. The Journal of investigative dermatology. Sep 8 2023.https://www.ncbi.nlm.nih.gov/pubmed/37690707
- Muntyanu A, Nechaev V, Pastukhova E, et al. Burden and geographic distribution of oral cavity and oropharyngeal cancers in the Russian Federation. Frontiers in oncology. 2023;13:1197287.https://www.ncbi.nlm.nih.gov/pubmed/37601694
- Nguyen A, Xie P, Litvinov IV, Lefrançois P. Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009-2022). Am J Clin Dermatol. Feb 16 2023.https://pubmed.ncbi.nlm.nih.gov/36795228/
Other
- Etchegary H, Linklater S, Duquette D, et al. “I think there has to be a mutual respect for there to be value”: Evaluating patient engagement in a national clinical trial on de-implementation of low value care. Res Involv Engagem. Aug 26 2023;9(1):70.https://www.ncbi.nlm.nih.gov/pubmed/37633983
- Pope E, Lara-Corrales I, Rehmus W, et al. Pediatric Dermatology in Canada: A Broad Review of Population Needs, Workforce and Training With Proposed Solutions. J Cutan Med Surg. Oct 12 2023:12034754231204865.https://www.ncbi.nlm.nih.gov/pubmed/37823355
- Akuffo-Addo E, George A, Ogunyemi B. Skin of Color Representation at the Canadian Dermatology Association’s Annual Conferences. J Cutan Med Surg. Jul 26 2023:12034754231188441.https://www.ncbi.nlm.nih.gov/pubmed/37493270
- Joly-Chevrier M, Nguyen AX, Lesko-Krleza M, Lefrancois P. Performance of ChatGPT on a Practice Dermatology Board Certification Examination. J Cutan Med Surg. Jul 25 2023:12034754231188437.https://www.ncbi.nlm.nih.gov/pubmed/37489920
- Lagace F, D’Aguanno K, Prosty C, et al. The Role of Sex and Gender in Dermatology – From Pathogenesis to Clinical Implications. J Cutan Med Surg. Jul 4 2023:12034754231177582.https://www.ncbi.nlm.nih.gov/pubmed/37401812
SkIN Canada Executive Committee




